Sodium-potassium ATPase — Drug Target
All drugs that target Sodium-potassium ATPase — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 1 pipeline (1)
- AB-106, digoxin · Nuvation Bio Inc. · Cardiac glycoside · Cardiovascular
Digoxin inhibits the sodium-potassium ATPase pump.